Literature DB >> 26982038

Respiratory therapy: a problem among children and adolescents with cystic fibrosis.

Taiane Dos Santos Feiten1, Josani Silva Flores2, Bruna Luciano Farias3, Paula Maria Eidt Rovedder2, Eunice Gus Camargo1, Paulo de Tarso Roth Dalcin2, Bruna Ziegler1.   

Abstract

OBJECTIVE: To evaluate the level of self-reported adherence to physical therapy recommendations in pediatric patients (6-17 years) with cystic fibrosis (CF) and to ascertain whether the different levels of adherence correlate with pulmonary function, clinical aspects, and quality of life.
METHODS: This was a cross-sectional study. The patients and their legal guardians completed a questionnaire regarding adherence to physical therapy recommendations and a CF quality of life questionnaire. We collected demographic, spirometric, and bacteriological data, as well as recording the frequency of hospitalizations and Shwachman-Kulczycki (S-K) clinical scores.
RESULTS: We included 66 patients in the study. Mean age, FEV1 (% of predicted), and BMI were 12.2 ± 3.2 years, 90 ± 24%, and 18.3 ± 2.5 kg/m2, respectively. The patients were divided into two groups: high-adherence (n = 39) and moderate/poor-adherence (n = 27). No statistically significant differences were found between the groups regarding age, gender, family income, and total S-K clinical scores. There were statistically significant differences between the high-adherence group and the moderate/poor-adherence group, the latter showing lower scores for the "radiological findings" domain of the S-K clinical score (p = 0.030), a greater number of hospitalizations (p = 0.004), and more days of hospitalization in the last year (p = 0.012), as well as lower scores for the quality of life questionnaire domains emotion (p = 0.002), physical (p = 0.019), treatment burden (p < 0.001), health perceptions (p = 0.036), social (p = 0.039), and respiratory (p = 0.048).
CONCLUSIONS: Low self-reported adherence to physical therapy recommendations was associated with worse radiological findings, a greater number of hospitalizations, and decreased quality of life in pediatric CF patients.

Entities:  

Mesh:

Year:  2016        PMID: 26982038      PMCID: PMC4805384          DOI: 10.1590/S1806-37562016000000068

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  22 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Thin-section CT in patients with cystic fibrosis: correlation with peak exercise capacity and body mass index.

Authors:  Jonathan D Dodd; Sinead C Barry; Rupert B M Barry; Charles G Gallagher; Stephen J Skehan; James B Masterson
Journal:  Radiology       Date:  2006-07       Impact factor: 11.105

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

4.  Disease specific knowledge about cystic fibrosis, patient education and counselling in Poland.

Authors:  Sławomir Chomik; Beata Klincewicz; Wojciech Cichy
Journal:  Ann Agric Environ Med       Date:  2014       Impact factor: 1.447

5.  Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: a prospective, randomized study.

Authors:  Franziska Ihle; Claus Neurohr; Patrick Huppmann; Gregor Zimmermann; Hanno Leuchte; Rainer Baumgartner; Klaus Kenn; Bernd Sczepanski; Rudolf Hatz; Stephan Czerner; Lorenz Frey; Peter Ueberfuhr; Iris Bittmann; Jürgen Behr
Journal:  J Heart Lung Transplant       Date:  2011-04-13       Impact factor: 10.247

6.  Quality of life assessment in patients with cystic fibrosis by means of the Cystic Fibrosis Questionnaire.

Authors:  Milena Antonelli Cohen; Maria Ângela Gonçalves de Oliveira Ribeiro; Antonio Fernando Ribeiro; José Dirceu Ribeiro; André Moreno Morcillo
Journal:  J Bras Pneumol       Date:  2011 Mar-Apr       Impact factor: 2.624

7.  Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis.

Authors:  Avani C Modi; Amy E Cassedy; Alexandra L Quittner; Frank Accurso; Marci Sontag; Joni M Koenig; Richard F Ittenbach
Journal:  J Pediatr Psychol       Date:  2010-03-18

8.  Family Functioning and Treatment Adherence in Children and Adolescents with Cystic Fibrosis.

Authors:  Robin S Everhart; Barbara H Fiese; Joshua M Smyth; Adrienne Borschuk; Ran D Anbar
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-06-01       Impact factor: 1.349

9.  Treatment compliance in children and adults with cystic fibrosis.

Authors:  Rosa Patricia Arias Llorente; Carlos Bousoño García; Juan José Díaz Martín
Journal:  J Cyst Fibros       Date:  2008-03-04       Impact factor: 5.482

Review 10.  State of progress in treating cystic fibrosis respiratory disease.

Authors:  Patrick A Flume; Donald R Van Devanter
Journal:  BMC Med       Date:  2012-08-10       Impact factor: 8.775

View more
  3 in total

1.  Developing Digital Games to Address Airway Clearance Therapy in Children With Cystic Fibrosis: Participatory Design Process.

Authors:  Fabio Balli
Journal:  JMIR Serious Games       Date:  2018-11-21       Impact factor: 4.143

2.  Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data.

Authors:  Héloïse Rouzé; Marie Viprey; Samuel Allemann; Alexandra L Dima; Pascal Caillet; Angélique Denis; Stéphanie Poupon-Bourdy; Boubou Camara; Catherine Llerena; Philippe Reix; Isabelle Durieu; Quitterie Reynaud; Sandrine Touzet
Journal:  Patient Prefer Adherence       Date:  2019-09-04       Impact factor: 2.711

3.  TREATMENT ADHERENCE AMONG CHILDREN AND ADOLESCENTS IN A CYSTIC FIBROSIS REFERENCE CENTER.

Authors:  Bianca Sampaio Bonfim; Valmir Machado de Melo Filho; Fernanda Matos Fontenelle; Edna Lúcia Souza
Journal:  Rev Paul Pediatr       Date:  2020-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.